Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.160
+0.070 (2.27%)
Aug 17, 2026, 1:52 PM EDT - Market open
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $562.18 million as of August 17, 2026. Its market cap has decreased by -6.83% in one year.
Market Cap
562.18M
Enterprise Value
579.58M
1-Year Change
-6.83%
Ranking
Category
Stock Price
$3.16
ChartMarket Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $562.18M, a decrease of -65.46%. That is a compound annual growth rate of -24.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 562.18M | -8.49% |
| Dec 31, 2025 | 614.32M | 64.88% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
| Oct 20, 2022 | 1.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Autolus Therapeutics | 572.25M |
| Altimmune | 571.88M |
| Prelude Therapeutics | 571.62M |
| ARS Pharmaceuticals | 561.88M |
| Artiva Biotherapeutics | 559.79M |
| Ovid Therapeutics | 552.69M |
| MapLight Therapeutics | 544.94M |
| Contineum Therapeutics | 533.84M |